NIAID Division of AIDS (DAIDS) Clinical Site Monitoring
- Institution
- PPD DEVELOPMENT LP, NC
- Principal investigator
- Kimberly Smith
- Funding
- $24.4M
- Duration
- 2025–2026
Moonbase score
Still being scored
Abstract
The National Institute of Allergy and Infectious Diseases, Division of Acquired Immunodeficiency Syndrome (DAIDS) supports the advancement of therapies for HIV infection and its complications, and supports the development of HIV/AIDS vaccines and other prevention measures. Through grants and contracts, DAIDS sponsors Phase I, II, III and IV clinical trials to evaluate the safety and efficacy of therapeutics, vaccines and other preventive modalities. The purpose of the Clinical Site Monitoring contract will be to continue to provide comprehensive clinical site and study monitoring services for the NIAID/DAIDS clinical trial research portfolio, including the delivery of monitoring services for unanticipated DAIDS clinical research projects that may be required in response to emerging needs or public health emergencies.
LOADING MOONBASE SCORE
Questions for Ppd Development LP
Ppd Development LP hasn't set up its Moonbase portfolio yet, so questions about this research can't be asked here.
Related grants
Same researchers, same institution, same topic, scored first.
- NIH · Ppd Development LPNot yet scored
Clinical Trial Site Monitoring for PHOENIx MDR-TB
Kimberly Smith · $985K · 2025
- NIH · Johns Hopkins UniversityNot yet scored
Longitudinal Assessment of Eating-related Anxiety in Anorexia Nervosa
Kimberly Smith · $184K · 2022–2027
- NIH · Johns Hopkins UniversityNot yet scored
Longitudinal Assessment of Eating-related Anxiety in Anorexia Nervosa
Kimberly Smith · $54K · 2022–2027